ОБ ЭТОМ ЭПИЗОДЕ
Glutathione gets called the "master antioxidant," and the underlying biology really is important. But does that mean oral supplements, liposomal products or glutathione IVs deliver the sweeping detox, energy, immune and anti-aging benefits often attached to them?
John breaks down glutathione biology, the GSH/GSSG cycle, oral human data, NAC, skin-related research and the gap between changing a biomarker and changing a meaningful health outcome. The episode also covers the 2026 FDA warning and recalls involving compounded injectable glutathione and elevated endotoxin levels.
The key question: where does established biology end and wellness marketing begin?
Educational only. Not medical advice.
английский
США
РАСШИФРОВКА 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
ПОИСК ПРОШЛЫХ ЭПИЗОДОВ
Искать прошлые эпизоды Peptides Explained.
ДРУГИЕ ЭПИЗОДЫ В ЭТОМ ПОДКАсте
For more information on Research Peptides go to PeptidesExplained.info/OfflinePeptides
Is taking smaller GLP-1 doses multiple times per week actually "microdosing"? Not necessarily.
This episode separates split dosing from true dose reduction and explains the pharmacokinetic logic using semagluti…
Follistatin can bind myostatin—one of the body's major restraints on skeletal-muscle growth. Animal studies are dramatic, and small human gene-therapy studies have produced encouraging signals in serious muscle disease.
But is a vial labeled "Follistatin-344" equivalent to the therapy used in thos…
If BPC-157, TB-500, KPV, MOTS-C and similar peptides are so interesting, why don't we have giant randomized human trials?
This episode looks at the less dramatic—and more important—answer: clinical trials require a sponsor, regulatory strategy, manufacturing package, defined indication, safety pro…
Download The Peptide App at ThePeptide.App/Explained
For more information on research peptides check out PeptidesExplained.info/OfflinePeptides
A peptide…in a pill?
Icotyde, or icotrokinra, is an FDA-approved oral peptide designed to block the IL-23 receptor in moderate-to-severe plaque psoriasi…
Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из John Garrett, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.
ИЗМЕНИТЬ
Спасибо, что помогаете поддерживать базу подкастов актуальной.
